We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
ATP1A1
  • premium

    TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS PANCREATIC CANCER

GENE/PROTEIN

Antibody validation

Dictionary

Pancreatic cancer

PANCREATIC CANCER - Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival, using best separation (to the left) and median separation (to the right). Patients were divided based on level of expression into one of the two groups "low" or "high". Below each Kaplan-Meier plot, corresponding expression cutoff, 5-year survival for patients with high expression, 5-year survival for patients with low expression and log-rank P value are displayed. For melanoma and glioma, 3-year survival is shown. The survival analysis is described in Assays & Annotation.

The tabs at the top of the survival analysis section can be used to switch between the different cancer subtypes.

Best separation

Median separation

Expression cutoffi

5-year survival for patients with higher expression than the expression cutoff.

111.7 FPKM 163.5 FPKM

5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

21% 28%

5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

55% 29%

Log-rank P valuei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

1.61e-2 3.58e-1

Interactive survival scatter plot (individual patient data)i

The Scatter Survival plot shows the clinical status for all individuals in the patient cohort, based on the same data as in the Kaplan-Meier plots. Living patients are shown in blue and deceased patients in red. The x-axis shows the expression levels (FPKM) of the investigated gene at the time of diagnosis and the y-axis shows the number of years of survival (living years) after the diagnosis.

Individual patient data is displayed in an interactive plot and can be filtered by clicking on one or several category buttons to the left. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be changed to "x linear" by clicking on the "x log" button on the left. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.




Stage:

TCGA RNA samplesi

RNA-seq data is reported as median FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average FPKM

172.2

Number of samples

176

Samples

Sample

Description

FPKM

TCGA-2J-AABO-01A 43 years, male, white, stage:iib 569.3
TCGA-S4-A8RO-01A 75 years, female, white, stage:iib 355.7
TCGA-FB-AAQ1-01A 49 years, male, white, stage:iib 352.3
TCGA-HZ-7924-01A 60 years, female, white, stage:iia 340.8
TCGA-HZ-7926-01A 57 years, male, black or african american, stage:iib 325.7
TCGA-HZ-A49G-01A 58 years, female, white, stage:iib 325.1
TCGA-IB-AAUW-01A 63 years, female, white, stage:iib 313.2
TCGA-IB-7649-01A 73 years, female, stage:iib 309.9
TCGA-IB-A6UF-01A 63 years, male, white, stage:iib 309.6
TCGA-HZ-7289-01A 77 years, male, white, stage:iib 293.0
TCGA-US-A77E-01A 73 years, male, white, stage:iib 289.6
TCGA-IB-7654-01A 80 years, male, white, stage:iib 287.8
TCGA-FB-A4P6-01A 54 years, male, white, stage:iib 287.3
TCGA-HV-A5A5-01A 61 years, female, asian, stage:iib 286.4
TCGA-HZ-A9TJ-01A 70 years, male, white, stage:iv 279.0
TCGA-2L-AAQI-01A 66 years, male, white, stage:iib 274.2
TCGA-HZ-7918-01A 72 years, male, white, stage:iib 272.6
TCGA-HZ-8002-01A 61 years, male, white, stage:iib 270.6
TCGA-2J-AABR-01A 60 years, female, white, stage:iia 265.8
TCGA-FB-AAPP-01A 71 years, male, white, stage:iib 263.2
TCGA-2J-AAB4-01A 48 years, male, white, stage:iib 261.8
TCGA-H6-8124-01A 56 years, female, white, stage:iib 253.9
TCGA-HZ-A4BK-01A 72 years, male, white, stage:iib 252.1
TCGA-2J-AAB1-01A 65 years, male, white, stage:iib 252.0
TCGA-2J-AABF-01A 73 years, male, white, stage:iib 249.7
TCGA-IB-AAUT-01A 65 years, male, white, stage:iib 249.2
TCGA-3E-AAAY-01A 67 years, male, white, stage:iib 247.3
TCGA-HZ-A49I-01A 77 years, male, white, stage:iib 243.0
TCGA-F2-7276-01A 64 years, male, white, stage:iib 242.8
TCGA-HV-AA8X-01A 75 years, female, asian, stage:iib 238.3
TCGA-XN-A8T3-01A 67 years, male, white, stage:ib 237.1
TCGA-XD-AAUL-01A 56 years, male, white, stage:iia 234.8
TCGA-3A-A9IX-01A 40 years, male, white, stage:ia 233.9
TCGA-2J-AABA-01A 55 years, male, white, stage:iib 232.2
TCGA-US-A779-01A 54 years, female, white, stage:iib 231.7
TCGA-US-A774-01A 76 years, female, white, stage:iib 228.4
TCGA-F2-A8YN-01A 76 years, male, white, stage:iia 226.1
TCGA-F2-7273-01A 54 years, male, black or african american, stage:iib 225.7
TCGA-HZ-7919-01A 52 years, female, white, stage:iib 224.7
TCGA-2J-AAB9-01A 71 years, female, white, stage:iib 223.0
TCGA-FB-AAPY-01A 71 years, male, white, stage:iib 222.5
TCGA-3A-A9IZ-01A 47 years, male, white, stage:iib 219.1
TCGA-FB-AAPU-01A 41 years, female, asian, stage:iia 217.9
TCGA-US-A77G-01A 64 years, male, white, stage:iib 216.5
TCGA-LB-A8F3-01A 64 years, female, black or african american, stage:iia 214.3
TCGA-IB-7891-01A 49 years, female, white, stage:iib 213.8
TCGA-FB-AAPZ-01A 54 years, male, white, stage:iib 213.2
TCGA-IB-7887-01A 62 years, female, white, stage:iib 210.9
TCGA-IB-AAUM-01A 76 years, male, white, stage:iib 206.8
TCGA-IB-AAUU-01A 35 years, male, white, stage:iib 204.8
TCGA-2J-AABU-01A 56 years, male, white, stage:iib 203.5
TCGA-2J-AABK-01A 71 years, male, white, stage:iib 201.7
TCGA-F2-6879-01A 57 years, male, white, stage:iib 199.0
TCGA-HZ-8315-01A 54 years, female, white, stage:iia 197.6
TCGA-S4-A8RP-01A 77 years, female, white, stage:iib 196.9
TCGA-FB-AAQ2-01A 81 years, female, white, stage:iib 194.8
TCGA-IB-A6UG-01A 65 years, male, white, stage:iib 194.2
TCGA-IB-7652-01A 49 years, female, asian, stage:iib 194.0
TCGA-RL-AAAS-01A 60 years, female, white, stage:ib 193.6
TCGA-M8-A5N4-01A 48 years, female, stage:iia 192.5
TCGA-HZ-8317-01A 69 years, female, white, stage:iib 190.7
TCGA-3A-A9I7-01A 45 years, male, black or african american, stage:iib 190.5
TCGA-H8-A6C1-01A 53 years, male, white, stage:iia 189.7
TCGA-IB-A7LX-01A 57 years, male, white, stage:iib 188.1
TCGA-HV-A5A6-01A 65 years, female, asian, stage:iib 186.4
TCGA-PZ-A5RE-01A 44 years, female, white, stage:iib 184.7
TCGA-3A-A9IH-01A 66 years, female, white, stage:ia 183.3
TCGA-IB-7651-01A 64 years, female, white, stage:iib 178.6
TCGA-3A-A9IB-01A 69 years, female, white, stage:iib 177.3
TCGA-3A-A9J0-01A 75 years, male, white, stage:iib 176.9
TCGA-IB-8126-01A 80 years, female, white, stage:iii 175.6
TCGA-Q3-AA2A-01A 64 years, female, white, stage:ib 175.1
TCGA-HZ-8638-01A 84 years, female, white, stage:ia 175.0
TCGA-XD-AAUI-01A 50 years, female, white, stage:iib 174.7
TCGA-3A-A9IJ-01A 65 years, male, white, stage:ib 174.5
TCGA-FB-AAQ3-01A 65 years, female, white, stage:iib 174.5
TCGA-FB-A4P5-01A 69 years, female, white, stage:iib 174.1
TCGA-IB-7644-01A 65 years, female, white, stage:iv 171.5
TCGA-IB-8127-01A 59 years, male, white, stage:iib 170.9
TCGA-HZ-7920-01A 71 years, male, white, stage:ib 169.7
TCGA-IB-A5SP-01A 77 years, male, white, stage:iia 169.3
TCGA-LB-A7SX-01A 74 years, female, black or african american, stage:iib 169.2
TCGA-RB-AA9M-01A 43 years, male, white, stage:iib 168.9
TCGA-IB-AAUN-01A 74 years, female, white, stage:ib 167.8
TCGA-2L-AAQJ-01A 49 years, female, white, stage:iii 167.8
TCGA-F2-6880-01A 70 years, male, white, stage:iib 167.1
TCGA-3A-A9IR-01A 64 years, female, white, stage:ib 165.4
TCGA-FB-A78T-01A 71 years, female, white, stage:iib 164.0
TCGA-H6-A45N-01A 88 years, female, white, stage:iib 163.1
TCGA-2J-AABH-01A 61 years, male, white, stage:iia 161.2
TCGA-HV-AA8V-01A 50 years, male, asian, stage:iib 160.6
TCGA-L1-A7W4-01A 48 years, female, white, stage:iib 158.4
TCGA-HZ-A77O-01A 77 years, female, white, stage:iib 157.8
TCGA-F2-A7TX-01A 77 years, male, white, stage:iib 157.8
TCGA-3A-A9I9-01A 67 years, male, white, stage:iia 157.8
TCGA-F2-A44G-01A 79 years, female, white, stage:iib 157.7
TCGA-IB-7645-01A 44 years, female, stage:iib 157.2
TCGA-IB-A5SQ-01A 56 years, female, white, stage:ib 157.2
TCGA-IB-7885-01A 78 years, female, white, stage:iib 155.1
TCGA-LB-A9Q5-01A 63 years, female, white, stage:iib 154.0
TCGA-HV-A5A4-01A 72 years, female, asian, stage:iia 153.6
TCGA-3A-A9I5-01A 58 years, male, white 150.5
TCGA-HZ-8005-01A 81 years, male, white, stage:iib 150.4
TCGA-2J-AAB6-01A 75 years, male, white, stage:iia 146.6
TCGA-IB-AAUP-01A 68 years, male, white, stage:iib 146.4
TCGA-3A-A9IU-01A 65 years, male, white, stage:iib 144.0
TCGA-XD-AAUG-01A 66 years, female, white, stage:iv 142.4
TCGA-HZ-A77P-01A 77 years, male, white, stage:iib 142.4
TCGA-HZ-A77Q-01A 55 years, female, white, stage:iib 142.3
TCGA-US-A77J-01A 81 years, female, white, stage:iib 141.3
TCGA-FB-AAPQ-01A 65 years, male, white, stage:iib 140.4
TCGA-IB-7897-01A 54 years, female, white, stage:iib 140.4
TCGA-IB-A5ST-01A 64 years, female, white, stage:iib 139.7
TCGA-HZ-7923-01A 65 years, male, white, stage:iia 138.7
TCGA-IB-AAUQ-01A 50 years, male, white, stage:iib 138.3
TCGA-IB-AAUO-01A 64 years, female, white, stage:iib 137.3
TCGA-FB-A545-01A 72 years, female, white, stage:iib 135.9
TCGA-HZ-A4BH-01A 75 years, male, white, stage:iib 135.4
TCGA-HZ-A49H-01A 68 years, female, white, stage:iib 134.6
TCGA-IB-A7M4-01A 81 years, male, white, stage:iib 133.1
TCGA-IB-7889-01A 86 years, female, white, stage:iib 132.1
TCGA-2L-AAQE-01A 56 years, male, white, stage:iib 131.4
TCGA-HV-A5A3-01A 50 years, male, asian, stage:iia 130.5
TCGA-HZ-8003-01A 65 years, female, white, stage:iib 128.7
TCGA-HZ-7922-01A 61 years, female, white, stage:iib 128.2
TCGA-S4-A8RM-01A 67 years, male, white, stage:iib 126.7
TCGA-IB-A5SS-01A 64 years, female, white, stage:iib 125.4
TCGA-2J-AABT-01A 72 years, female, white, stage:iib 124.5
TCGA-YY-A8LH-01A 61 years, female, white, stage:iib 123.6
TCGA-HZ-8636-01A 58 years, female, white, stage:iv 123.5
TCGA-FB-AAQ6-01A 85 years, male, white, stage:ia 122.6
TCGA-YB-A89D-01A 59 years, male, white, stage:iib 122.5
TCGA-RB-A7B8-01A 81 years, female, white, stage:iib 122.2
TCGA-IB-7888-01A 66 years, female, black or african american, stage:iia 121.6
TCGA-IB-A5SO-01A 71 years, male, white, stage:iib 119.2
TCGA-HZ-7925-01A 66 years, male, white, stage:iib 116.9
TCGA-HZ-8519-01A 73 years, male, white, stage:ia 112.9
TCGA-F2-A44H-01A 65 years, male, white, stage:iia 112.1
TCGA-IB-7646-01A 60 years, male, white, stage:iib 111.8
TCGA-2J-AABE-01A 73 years, male, white, stage:iia 111.6
TCGA-IB-7886-01A 80 years, male, white, stage:iib 110.6
TCGA-US-A776-01A 61 years, male, white, stage:iia 110.5
TCGA-2L-AAQL-01A 82 years, male, white, stage:iib 108.2
TCGA-XN-A8T5-01A 53 years, female, white, stage:ib 108.1
TCGA-FB-A5VM-01A 74 years, male, white, stage:ib 105.9
TCGA-FB-AAQ0-01A 68 years, male, white, stage:iia 104.1
TCGA-2J-AABV-01A 74 years, male, white, stage:iib 104.0
TCGA-IB-7893-01A 64 years, male, white, stage:iia 103.0
TCGA-IB-AAUS-01A 84 years, female, white, stage:iib 102.8
TCGA-HV-A7OL-01A 70 years, male, asian, stage:iia 101.7
TCGA-IB-7890-01A 73 years, male, stage:ib 97.2
TCGA-HZ-8001-01A 69 years, male, white, stage:iii 96.3
TCGA-3A-A9IC-01A 61 years, female, white, stage:iib 91.5
TCGA-2J-AAB8-01A 71 years, male, white, stage:iib 91.2
TCGA-FB-AAPS-01A 62 years, female, white, stage:iib 90.4
TCGA-XD-AAUH-01A 57 years, female, white, stage:iib 88.7
TCGA-2J-AABI-01A 55 years, female, white, stage:iia 86.4
TCGA-HZ-A8P1-01A 81 years, male, white, stage:ib 85.9
TCGA-FB-A7DR-01A 48 years, male, asian, stage:iia 85.7
TCGA-3A-A9IL-01A 39 years, female, white, stage:i 85.3
TCGA-IB-AAUV-01A 49 years, male, white, stage:iib 85.1
TCGA-HZ-8637-01A 76 years, female, white, stage:iib 84.9
TCGA-IB-AAUR-01A 67 years, male, white, stage:iib 84.7
TCGA-YH-A8SY-01A 73 years, female, white 81.3
TCGA-2J-AABP-01A 58 years, female, white, stage:iib 76.2
TCGA-3E-AAAZ-01A 71 years, male, white, stage:iia 76.1
TCGA-Z5-AAPL-01A 74 years, female, white, stage:iia 74.5
TCGA-OE-A75W-01A 75 years, male, white, stage:iia 71.0
TCGA-2L-AAQA-01A 76 years, male, white, stage:iib 70.1
TCGA-3A-A9IS-01A 67 years, male, white, stage:ib 65.3
TCGA-HV-A7OP-01A 72 years, male, asian, stage:iib 64.9
TCGA-Q3-A5QY-01A 58 years, male, white, stage:iib 64.5
TCGA-3A-A9IN-01A 62 years, female, white, stage:ib 55.3
TCGA-3A-A9IV-01A 59 years, female, white, stage:ib 46.6
TCGA-3A-A9IO-01A 56 years, male, white 46.3
TCGA-2L-AAQM-01A 52 years, male, white, stage:iib 46.2
Show all

PANCREATIC CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody CAB018702

Antibody CAB069993

 Antibody staining
  High
  Medium
  Low
  Not detected
   
 Intensity
  Strong
  Moderate
  Weak
  Negative
   
 Quantity
  >75%
  75%-25%
  <25%
  Rare
  Negative
   
 Location
  Cytoplasmic/membranous,nuclear
  Cytoplasmic/membranous
  Nuclear
  None
   

Click images for details

































Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.